Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Comment by NewToInvesting7on Aug 19, 2023 8:48am
102 Views
Post# 35596115

RE:RE:RE:RE:RE:RE:Conference call

RE:RE:RE:RE:RE:RE:Conference call
NewToInvesting7 wrote:
Liked2Think wrote:

Hahaha

i didn't even know it had that many views until you pointed it out

i forgot you always got butt hurt if someone had likes on a post like it matters. This isn't Facebook you have no "friends" here

what is the benefit of views anyway?  Obviously it gets you all hot and bothered so there must be some reason for someone to do that. 

the know there is only two things that matter with this company
1. 99.6% drop in sp to .065 a share
2. constant lies from management

no number of likes or views change that fact 



99.6% drop?  Yes, from the all-time high in 2015.  Otherwise a 96% drop from the 3-year high.

Constant lies?  Not sure.  But definitely a few misrepresentations for sure (and some material).  Intent is hard to prove.  [I didn't follow the Oncore deal.  but the $4m Care revenues is tricky because it could be that Care made $4m before StageZero acquired part of the business - we only know that NRs and James mentioned $4m but no additional details provided].

Not sure James can turn this around without significant help.  He needs to step back and hire two experienced officers - a CCO (chief commericial officer) & a COO.  Dip into the GEM funding, get established people with a proven track record and pay them well.  Have the compensation packages structured so that it rewards results.

James also needs to dip into his own pockets and start buying significant shares in the public market (1m+).

Can StageZero become profitable and turn around (even with a Cancer test)?  For sure.  Won't be easy and will take some time.  Better and different leadership is required.  

Cheers!


That last comment should have said 

Can StageZero become profitable and turn around (even WITHOUT a Cancer test)?  For sure.  Won't be easy and will take some time.  Better and different leadership is required. 
<< Previous
Bullboard Posts
Next >>